Status: Recruiting
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
The Investigators will investigate the efficacy of combining the standalone iStent infinite and iDose that are minimally invasive surgical and drug depot options are a safe and effective alternative to filtering surgery for intraocuar pressure reduction in patients with medically uncontrolled open angle glaucoma.
Participants needed: 20
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Jonathon MyersUpdated: Nov 14, 2025Locations: 1
Eligibility criteria
Moderate to severe open angle glaucoma (including POAG, PG, and PXG) [+6]
Traumatic, uveitic, neovascular glaucoma, or angle closure glaucoma [+4]